Key Highlights
- Matthias Evers, Ph.D., appointed as an independent director at IMIDomics.
- Dr. Evers brings decades of expertise in life sciences, drug development, and biotech strategy.
- His experience aligns with IMIDomics’ data-driven approach to developing precision therapies.
Source: Business Wire
Notable Quotes
- “IMIDomics’ integration of multi-omics data with clinical insights presents a massive opportunity to accelerate the development of precision therapies.” — Dr. Matthias Evers, Independent Director at IMIDomics, Inc
- “His deep experience in fostering innovative partnerships and driving life sciences discoveries to the market aligns perfectly with our focus on advancing our pharmaceutical pipeline.” — Dr. Fred Craves, Chairman and CEO at IMIDomics
SoHC's Take
Dr. Evers’ appointment is a strategic move for IMIDomics as the company continues to advance its focus on immune-mediated inflammatory diseases (IMIDs). His global expertise in drug discovery, particularly with the integration of AI and PanOmics-driven approaches, will be a vital asset in accelerating IMIDomics’ precision medicine initiatives. This leadership addition reflects the company’s commitment to translating complex biological data into meaningful therapies, ultimately benefiting patients with limited or no treatment options.
Heading
Key Highlights New Mountain Capital is backing SmarterDx at a billion-dollar valuation, according to a source familiar with the transaction.SmarterDx ...
Episode Details: Join us on the latest episode, hosted by Jared S. Taylor! Our Guest: Navin Gupta, CEO at Viventium & Hadas Nahon, ...
Episode Details Join us on the latest episode! Our Guest: Michael Oleksiw, CEO at Pleio. What you'll get out of ...
Key Highlights Babson Diagnostics partners with Sam’s Clubto expand BetterWay™ blood testingSeven Austin-area Sam’s Club pharmaciesto offer testing, starting with ...
Key Highlights Jeannette Bankes appointed President & CEO, Patient Care SolutionsEffective May 1, 2025, following Tom Westrick’s retirementBrings 30 years of ...
Key Highlights New AI feature translates everyday language into clinical termsDelivers personalized care guidance with a 99% match rateValidated by ...
